Western Midstream Announces Third-Quarter 2026 Results

Western Midstream reported Q3 2026 Adjusted EBITDA of $708.3 million, up 12% year over year, and record natural-gas throughput of 5.9 Bcf/d, up 8% sequentially; net income attributable to limited partners was $324.8 million. WES reaffirmed 2026 Adjusted EBITDA guidance of $2.75–$2.95 billion and expects full-year results above the midpoint, while anticipating capital expenditures slightly above the $850 million–$1.0 billion range. The quarterly distribution remains $0.930 per unit ($3.72 annualized); Free Cash Flow after distributions was negative $148.5 million due to organic growth capital spending.

Analysis

The key signal is volume growth without equivalent unit economics. Higher Delaware gas volumes—partly acquisition-driven—are being offset by lower per-unit gross margins across gas, liquids, and water, while quarterly EBITDA eased sequentially. That makes the headline throughput records a weaker read-through to organic earnings power than the growth narrative implies; verify how much of the 2027 ramp is incremental, retained-margin volume versus acquired or lower-margin throughput.

Distribution coverage remains supported by DCF, but growth spending is consuming cash after distributions. The mismatch matters: DCF excludes growth capex, whereas reported free cash flow captures it. Debt has also risen since year-end and cash is modest, so the “investment-grade/liquidity” assertion should be checked against revolver availability, maturities, and leverage covenants before treating the distribution as insulated. Solitude is a long-dated capacity option, not a near-term cash-flow catalyst; its 2029–30 start dates expose WES to execution and Permian supply timing risk.

Near term, the Nov. 5 call can clarify Q4 well starts, integration/offload savings, and capex funding. Over 1–3 months, watch whether Q4 delivery converts guidance optimism into cash generation. Over 6–18 months, sustained producer activity and new projects could lift throughput, but margin-per-unit stabilization is the more important confirmation. Contrarian read: investors may over-credit volume and underweight declining unit margins and growth-capex drag; conversely, the unchanged distribution and fee-based exposure may cushion downside if volumes hold.

Key Decisions for Investors

• Treat WES as an income/volume-growth position, not a clean margin-expansion trade; avoid adding solely on record throughput until the call quantifies organic versus Brazos contribution and the expected margin on incremental volumes.
• For current holders, maintain exposure only while distribution coverage and funding remain credible. On the Nov. 5 call, verify revolver headroom, debt/EBITDA trajectory, 2027 growth-capex split, and whether the Solitude commitment is included in guidance; reassess if management signals debt-funded spending materially above plan.
• Watch Q4 and 2027 indicators: Delaware throughput excluding acquisition effects, per-unit adjusted gross margin by segment, offload costs after the Brazos tie-in, and free cash flow after distributions. A further margin decline alongside capex overrun would falsify the bullish operating-leverage case.
• No high-conviction directional trade without valuation and liquidity details. A relative-value long WES versus more commodity-sensitive upstream exposure is only a watch item: the thesis depends on fee-based cash flows holding up while producer volumes grow, and should be reconsidered if producer activity or WES distribution coverage weakens.